A new trial involving 12,000 college students from around 20 universities in the U.S. will focus on COVID-19 vaccines and the impact they have on asymptomatic transmission.
A new trial involving 12,000 college students from around 20 universities in the U.S. will focus on COVID-19 vaccines and the impact they have on asymptomatic transmission.